1            Broadly neutralizing antibodies (bNAbs) to HIV-1 can prevent infection and are therefore of great importance f

2   Passive transfer of neutralizing antibodies against HIV-1 can prevent infection in macaques and seems to delay HIV-1 re

3 ls have shown that broadly neutralizing antibodies to HIV-1 can prevent infection, suggesting that a vaccine that elicits

4                                                Although Abs can prevent infection, disease and death can be prevented by

5     Passive transfer of broadly neutralizing HIV antibodies can prevent infection, which suggests that vaccines that elic

6                                            These antibodies can prevent infection and suppress viraemia in humanized mice

7                  When administered passively, this antibody can prevent infection in animal models and suppress viremia i

8 s (Osps) A, B, and C of the spirochete Borrelia burgdorferi can prevent infection in animal models of Lyme borreliosis.

9 that sufficient levels of neutralizing antibody against HIV can prevent infection, although the effect is type-specific.

10  hours of a percutaneous or mucous membrane exposure to HIV can prevent infection.

11 HIV-1 develops broadly neutralizing antibodies (bNAbs) that can prevent infection, but it has not yet been possible to el

12        Therefore, it is important to develop a vaccine that can prevent infection by both lethal species.

13  the field of AIDS research, an effective AIDS vaccine that can prevent infection remains elusive.